| rs7744392 |
chr6 |
35322763 |
0.0000234 |
A |
G |
Femoral neck bone geometry |
PPARD |
intron |
22087292
|
| rs7744392 |
chr6 |
35322763 |
0.00000391 |
A |
G |
Body mass index |
PPARD |
intron |
22885924
|
| rs7744392 |
chr6 |
35322763 |
0.000003 |
A |
G |
Cataracts in type 2 diabetes |
PPARD |
intron |
23137000
|
| rs6901410 |
chr6 |
35330030 |
0.0000209 |
T |
C |
HIV-1 infection (natural long-term nonprogression) |
PPARD |
intron |
22238471
|
| rs9470003 |
chr6 |
35337931 |
0.0000000013 |
G |
C,T |
Height |
PPARD |
intron |
21998595
|
| rs9470004 |
chr6 |
35341850 |
0.00000000001 |
C |
T |
Height |
PPARD |
intron |
21998595
|
| rs6922548 |
chr6 |
35353523 |
1 |
A |
G |
Drug response to Docetaxel |
PPARD |
intron |
20038957
|
| rs6922548 |
chr6 |
35353523 |
1 |
A |
G |
Drug response to Thalidomide |
PPARD |
intron |
20038957
|
| rs16868709 |
chr6 |
35354471 |
0.000099 |
C |
G |
Height |
PPARD |
intron |
21998595
|
| rs9658100 |
chr6 |
35356640 |
0.0000239 |
T |
G |
HIV-1 infection (natural long-term nonprogression) |
PPARD |
intron |
22238471
|
| rs9462078 |
chr6 |
35357974 |
0.000000049 |
A |
G |
Height |
PPARD |
intron |
21998595
|
| rs7769719 |
chr6 |
35362525 |
1 |
G |
A |
Drug response to Docetaxel |
PPARD |
intron |
20038957
|
| rs7769719 |
chr6 |
35362525 |
1 |
G |
A |
Drug response to Thalidomide |
PPARD |
intron |
20038957
|
| rs9658108 |
chr6 |
35363757 |
0.0000005 |
C |
G |
Response to antipsychotic treatment |
PPARD |
intron |
20195266
|
| rs9658113 |
chr6 |
35364794 |
0.000000000000821 |
C |
T |
HDL cholesterol |
PPARD |
intron |
23063622
|
| rs1883322 |
chr6 |
35369806 |
1 |
C |
T |
Drug response to Docetaxel |
PPARD |
intron |
20038957
|
| rs1883322 |
chr6 |
35369806 |
1 |
C |
T |
Drug response to Thalidomide |
PPARD |
intron |
20038957
|
| rs2267666 |
chr6 |
35370728 |
0.0000051 |
A |
T |
Urinary metabolites |
PPARD |
intron |
21572414
|
| rs2267667 |
chr6 |
35372524 |
0.0000071 |
G |
C |
Urinary metabolites |
PPARD |
intron |
21572414
|
| rs2038068 |
chr6 |
35374461 |
0.000096 |
A |
G |
Pericardial fat |
PPARD |
intron |
22589742
|
| rs9658131 |
chr6 |
35378735 |
0.000000177 |
G |
T |
Triglycerides |
PPARD |
intron |
23063622
|
| rs2016520 |
chr6 |
35378778 |
1 |
C |
T |
Drug response to Docetaxel |
PPARD |
UTR-5 |
20038957
|
| rs2016520 |
chr6 |
35378778 |
1 |
C |
T |
Drug response to Thalidomide |
PPARD |
UTR-5 |
20038957
|
| rs2299869 |
chr6 |
35383432 |
0.0000000206 |
C |
T |
HDL cholesterol |
PPARD |
intron |
23063622
|
| rs9462082 |
chr6 |
35386041 |
0.000865 |
A |
G |
Multiple complex diseases |
PPARD |
intron |
17554300
|
| rs9462082 |
chr6 |
35386041 |
0.0000013 |
A |
G |
Urinary metabolites |
PPARD |
intron |
21572414
|
| rs9658150 |
chr6 |
35387900 |
0.0000000146 |
G |
A |
LDL cholesterol |
PPARD |
intron |
23063622
|
| rs9658150 |
chr6 |
35387900 |
0.00000000000359 |
G |
A |
Triglycerides |
PPARD |
intron |
23063622
|
| rs2076169 |
chr6 |
35388479 |
0.000022 |
A |
G |
Urinary metabolites |
PPARD |
intron |
21572414
|
| rs3734254 |
chr6 |
35395010 |
1 |
C |
T |
Drug response to Docetaxel |
PPARD |
UTR-3 |
20038957
|
| rs3734254 |
chr6 |
35395010 |
1 |
C |
T |
Drug response to Thalidomide |
PPARD |
UTR-3 |
20038957
|
| rs3734254 |
chr6 |
35395010 |
0.00000000000011 |
C |
T |
Height |
PPARD |
UTR-3 |
21194676
|
| rs3734254 |
chr6 |
35395010 |
0.000004 |
C |
T |
Height |
PPARD |
UTR-3 |
21194676
|
| rs3734254 |
chr6 |
35395010 |
0.0000000041 |
C |
T |
Height |
PPARD |
UTR-3 |
21194676
|
| rs1053049 |
chr6 |
35395618 |
0.00000838 |
C |
T |
Coronary heart disease |
PPARD |
UTR-3 |
pha003031
|
| rs1053049 |
chr6 |
35395618 |
0.0000555 |
C |
T |
Left ventricular hypertrophy |
PPARD |
UTR-3 |
pha003052
|